BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24783075)

  • 1. Role of s-100 immunostaining in demonstration of nerve changes and quantification of dendritic cells in leprosy.
    Mohanraj A; Srinivasan S
    J Clin Diagn Res; 2014 Mar; 8(3):38-40. PubMed ID: 24783075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-100 protein in the diagnosis of tuberculoid/borderline tuberculoid leprosy.
    Khan AR
    Ann Saudi Med; 1998; 18(4):305-7. PubMed ID: 17344678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of S-100 Immunostain as An Auxiliary Diagnostic Aid in Leprosy.
    Dhakhwa R; Acharya S; Pradhan S; Shrestha SB; Itoh T
    JNMA J Nepal Med Assoc; 2017; 56(205):141-144. PubMed ID: 28598451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-100 as a useful auxiliary diagnostic aid in tuberculoid leprosy.
    Gupta SK; Nigam S; Mandal AK; Kumar V
    J Cutan Pathol; 2006 Jul; 33(7):482-6. PubMed ID: 16872470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-100 immunostaining in the Distinction of Borderline Tuberculoid Leprosy from other Cutaneous Granulomas.
    Tirumalae R; Stany AI; Shanubhogue S; Yeliur IK
    Indian J Dermatol; 2014 Jul; 59(4):421. PubMed ID: 25071276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micropathological changes in the sub-epidermal zone of normal appearing skin in leprosy.
    Rastogi R; Budhiraja V; Babu CS; Madan M; Krishna A; Asthana AK
    Rom J Morphol Embryol; 2011; 52(1):165-9. PubMed ID: 21424049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of a novel multiplex polymerase chain reaction assay as a sensitive tool for the diagnosis of indeterminate and tuberculoid forms of leprosy.
    Chaitanya VS; Cuello L; Das M; Sudharsan A; Ganesan P; Kanmani K; Rajan L; Ebenezer M
    Int J Mycobacteriol; 2017; 6(1):1-8. PubMed ID: 28317797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of S100 Immunostaining in Demonstrating Neural Granulomas in Paucibacillary Leprosy.
    Shenoy N; Nair NG
    Indian J Dermatol; 2018; 63(3):215-219. PubMed ID: 29937557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological assessment of dermal nerve damage occurring during multidrug therapy for leprosy.
    Jain M; Singh N; Bhatia A; Arora VK
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):167-71. PubMed ID: 11036497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of changes in the nasal mucosa in indeterminate, tuberculoid and borderline leprosy.
    Chacko CJ; Bhanu T; Victor V; Alexander R; Taylor PM; Job CK
    Lepr India; 1979 Jan; 51(1):8-22. PubMed ID: 376945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor.
    Modlin RL; Hofman FM; Horwitz DA; Husmann LA; Gillis S; Taylor CR; Rea TH
    J Immunol; 1984 Jun; 132(6):3085-90. PubMed ID: 6327818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of S-100 staining in differentiating leprosy from other granulomatous diseases of the skin.
    Thomas MM; Jacob M; Chandi SM; George S; Pulimood S; Jeyaseelan L; Job CK
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):1-5. PubMed ID: 10407622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Borderline Tuberculoid Leprosy With Type One Lepra Reaction.
    Harikrishna GV; Ca J; Doddapaneni S; Bhat N; Bhanu P
    Cureus; 2023 Apr; 15(4):e38081. PubMed ID: 37252606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers.
    K K; S S; K S
    Cureus; 2023 Apr; 15(4):e37968. PubMed ID: 37223172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological lesions of apparently normal skin in leprosy patients.
    Rashed HA; Mearag I; Saleh NM; Saied A
    J Egypt Soc Parasitol; 2009 Dec; 39(3):933-42. PubMed ID: 20120756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatoscopy in leprosy and its correlation with clinical spectrum and histopathology: a prospective observational study.
    Vinay K; Kamat D; Chatterjee D; Narang T; Dogra S
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1947-1951. PubMed ID: 31004456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T regulatory cells (TREG)(TCD4+CD25+FOXP3+) distribution in the different clinical forms of leprosy and reactional states.
    Parente JN; Talhari C; Schettini AP; Massone C
    An Bras Dermatol; 2015; 90(1):41-7. PubMed ID: 25672298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort.
    Lockwood DN; Suneetha L; Sagili KD; Chaduvula MV; Mohammed I; van Brakel W; Smith WC; Nicholls P; Suneetha S
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1327. PubMed ID: 22180790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathology of the lepromatous skin biopsy.
    Massone C; Belachew WA; Schettini A
    Clin Dermatol; 2015; 33(1):38-45. PubMed ID: 25432809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sural nerve biopsy in leprosy patients after varying periods of treatment: histopathological and bacteriological findings on light microscopy.
    Haimanot RT; Mshana RN; McDougall AC; Andersen JG
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):163-70. PubMed ID: 6539309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.